Could platypus venom help treat diabetes?
19 June, 2018A key metabolic hormone, glucagon-like peptide-1 (GLP-1), found in the venom and gut of the Australian platypus, will now be investigated for its potential to treat type 2 diabetes.
Research opens new pathways for vaccine development
18 June, 2018Burnet Institute researchers have identified a novel process used by the immune system to kill and clear malaria.
New blood test could predict heart attack
14 June, 2018Australian researchers have developed a blood test that improves the prediction of long-term risk of heart attack or death in those with severe coronary artery disease.
Fewer women than men meet criteria for heart failure trials
29 May, 2018Researchers have investigated why just 21% of patients enrolled in the PARADIGM-HF trial — which had a total of 8399 participants across 47 countries — were women.
Does cancer immunotherapy work better in men than women?
18 May, 2018Male cancer patients may benefit more from immunotherapy than female patients.
Bowel cancer researcher focuses on molecular analysis
14 May, 2018Professor Mark Molloy has been appointed the inaugural Lawrence Penn Chair of Bowel Cancer Research at the University of Sydney.
Improved diagnosis for glaucoma, the 'sneak thief of sight'
09 May, 2018Researchers have bridged a key knowledge gap in the diagnosis of glaucoma, allowing observable damage to the optic nerve to be accurately linked to vision loss.
Cancer Australia releases 'stage at diagnosis' data
30 April, 2018The landmark data reveals the extent and spread of the top five incidence cancers at diagnosis across four stages of severity.
Nanoscale sensor detects cytokine
26 April, 2018A newly developed sensor can detect signalling molecules — called cytokines — that operate in the living brain.
How much does cancer cost the Australian economy?
09 April, 2018Experiencing cancer is tough for any patient, as well as their family and friends. But it seems that cancer is also not great for the Australian economy.
Optimum treatment for advanced melanoma patients revealed
05 April, 2018Researchers now have greater clarity on the best course of treatment for patients with advanced melanoma which has spread to the brain.
Why are rheumatoid arthritis patients at risk of heart disease?
29 March, 2018Treating rheumatoid arthritis patients with a high-density lipoprotein (HDL) may limit their risk of developing heart disease, according to Melbourne researchers.
Less invasive glaucoma treatment gets approval
27 March, 2018A surgical treatment for glaucoma that involves implantation of a microfistula tube has been approved for general use in Australia.
Drug delays disability in secondary progressive MS
27 March, 2018A new drug is said to slow the progression of disability in secondary progressive multiple sclerosis (MS), according to a double-blind, randomised, phase III trial.
Alliance Agreement to advance laser-based cancer treatment
27 March, 2018The Hudson Institute and Invion have signed a Research & Development Alliance Agreement in order to advance the latter's cancer treatment technology, Photosoft.
